Holen Sie sich die Stockscreener-App
325.06
0.37%
1.21
Handel nachbörslich:
322.40
-2.66
-0.82%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$323.85
Offen:
$325.37
24-Stunden-Volumen:
959.15K
Relative Volume:
0.81
Marktkapitalisierung:
$62.03B
Einnahmen:
$328.68B
Nettoeinkommen (Verlust:
$2.55B
KGV:
24.94
EPS:
13.0349
Netto-Cashflow:
$1.56B
1W Leistung:
+3.22%
1M Leistung:
+1.09%
6M Leistung:
+1.32%
1J Leistung:
+2.22%
1-Tages-Spanne:
$323.64
$327.96
1-Wochen-Bereich:
$311.83
$327.96
52-Wochen-Spanne:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
325.06 | 62.03B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
955.76 | 111.43B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
238.08 | 55.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.23 | 9.39B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.37 | 1.17B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-19 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2026-04-28 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Hochstufung | Jefferies | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
Cencora stock trades at EUR 291.90 with USD 63.3 billion value - ad-hoc-news.de
XS307124629 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR) Has Investors Asking A Bigger Question - Simply Wall Street
Cencora appointed Robert Sanchez as analysts cite USD 372.07 target for Cencora stock - ad-hoc-news.de
US03073EBF16 Bond Profile: Coupon and Redemption - TradingView
ABC4571977 Bond Profile: Coupon and Redemption - TradingView
Cencora, Inc. (COR) Options Chain - Yahoo! Finance Canada
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Cencora Inc (1COR.MI) Q3 FY2026 earnings call transcript - Yahoo Finance
ABC4213751 Bond Profile: Coupon and Redemption - TradingView
COR Maintained by Cencora -- Price Target Raised to $388 - GuruFocus
Form 4 Cencora Inc For: 6 October By Investing.com - Investing.com Nigeria
ABC6310083 Bond Profile: Coupon and Redemption - TradingView
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow (NYSE:COR) - Seeking Alpha
Cencora Inc (COR) Insider Sale: SVP & Chief Accounting Officer L - GuruFocus
A 275-share stock grant for Cencora (COR) director Robert E. Sanchez vests in one year. - Stock Titan
Cencora Inc. R (ABG.MU) Q3 FY2026 earnings call transcript - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Under a trading plan, Cencora (COR) accounting chief sells 986 shares at $303.18 each. - Stock Titan
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release - marketscreener.com
Cencora Adds Ryder Veteran to Board as Logistics Focus Grows - MyChesCo
ABC6310082 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR) Adds Robert E. Sanchez To Its Board, Is The Stock Still Cheap? - Simply Wall Street
ABC5953320 Bond Profile: Coupon and Redemption - TradingView
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release - Yahoo Finance
Cencora Inc (COR) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 80/100 - GuruFocus
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
A revocable trust holds 197 Cencora (COR) shares for director Robert E. Sanchez. - stocktitan.net
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ABC5953643 Bond Profile: Coupon and Redemption - TradingView
Cencora stock pre-market at EUR 54.84: plus 0.49 percent - AD HOC NEWS
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
ETFs Investing in Cencora, Inc. Stocks - TradingView
Cencora elects Ryder executive Sanchez to board of directors - Pennsylvania Business Report -
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today - Benzinga
Cencora stock last trades at USD 305.26 on September 28, 2026 - AD HOC NEWS
Cencora Inc Lobbyists, 2014 - OpenSecrets
Cencora Inc Agencies, 2024 - OpenSecrets
Form 8K Cencora Inc For: 25 September By Investing.com - Investing.com Nigeria
Cencora Elects Former Ryder CEO Robert Sanchez to Board - citybiz
Cencora, Inc. Announces Appointment of Robert E. Sanchez as Independent Director, Effective October 1, 2026 - marketscreener.com
Robert E. Sanchez appointed to Cencora board effective Oct 1, 2026 - TradingView
Cencora appoints former Ryder CEO to board of directors - Investing.com
Cencora Elects Ryder Systems' Robert Sanchez to Board - Yahoo Finance
A former Ryder CEO joins Cencora's board Oct. 1 - stocktitan.net
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cencora Inc-Aktie (COR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GREENBERG LON R | Director |
Sep 16 '26 |
Sale |
321.30 |
1,280 |
411,264 |
17,128 |
| Lon Greenberg | Director |
Sep 16 '26 |
Proposed Sale |
321.31 |
1,280 |
411,282 |
0 |
| Battaglia Silvana | Former Officer |
Sep 11 '26 |
Proposed Sale |
325.00 |
1,324 |
430,300 |
0 |
| Cleary James F | Former Officer |
Sep 04 '26 |
Proposed Sale |
335.17 |
10,000 |
3,351,656 |
0 |
| Krikorian Lazarus | SVP & Chief Accounting Officer |
Sep 01 '26 |
Sale |
325.97 |
985 |
321,080 |
16,169 |
| Battaglia Silvana | Former Officer |
Sep 01 '26 |
Proposed Sale |
330.00 |
6,593 |
2,175,690 |
0 |
| Campbell Elizabeth S | Executive Vice President |
Aug 24 '26 |
Sale |
324.12 |
11,300 |
3,662,663 |
19,455 |
| Campbell Elizabeth S | Officer |
Aug 24 '26 |
Proposed Sale |
324.10 |
11,301 |
3,662,663 |
0 |
| Cleary James F | Officer |
Aug 06 '26 |
Proposed Sale |
316.65 |
20,000 |
6,333,096 |
0 |
| Tyler Lauren M | Director |
Jun 22 '26 |
Buy |
270.23 |
550 |
148,626 |
4,359 |
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):